Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ALZN | Stock Options (Right to Buy) | 0 | Nov 30, 2022 | Common Stock | 250K | $1.50 | Direct | F1 | |||||
holding | ALZN | Stock Options (Right to Buy) | 2M | Nov 30, 2022 | Common Stock | 2M | $0.00 | Direct | F2 | |||||
holding | ALZN | Stock Options (Right to Buy) | 250K | Nov 30, 2022 | Common Stock | 250K | $1.50 | Direct | F3 |
Id | Content |
---|---|
F1 | Mr. Horne was granted options, exercisable for 10 years, to purchase 250,000 shares of the Issuer's common stock, of which (i) 50% would vest if the Issuer's common stock closed at or above $10.00 per share for 90 consecutive trading days, and (ii) 10% would vest for each $2.00 per share increment above $10.00 per share for 90 consecutive trading days, with 100% vesting if the Issuer's common stock closed at or above $20.00 per share for 90 consecutive trading days. After November 27, 2026, the number of any unvested shares subject to the option would decrease by 25%. On November 22, 2022, the Issuer modified the vesting criteria of these options to reduce the price targets, which were previously between $10.00 and $40.00 per share, and to extend the period of time for vesting before the 25% of unvested shares subject to the option would be decreased. |
F2 | These options were fully vested on issuance. |
F3 | The stock options vested ratably over 36 months beginning on the date of grant. and are fully vested. |